← Back to Search

CALM Breathing for Chronic Obstructive Pulmonary Disease (CALM Trial)

N/A
Waitlist Available
Led By Naomi Simon, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult males or females
- DMQ-CAT dyspnea anxiety score ≤50; or
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

CALM Trial Summary

This trial is testing a new way to help people with COPD and anxiety sensitivity. It is based on previous feedback and will help to further develop the intervention.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease

CALM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Both men and women over 18 years old.
Select...
Your score on a questionnaire about your breathing and anxiety levels (DMQ-CAT) must be 50 or less.
Select...
You have high levels of anxiety related to shortness of breath.
Select...
During a walking test, you experience shortness of breath and anxiety that is rated as severe.
Select...
You get scared when you have trouble breathing.

CALM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability Aim #2 CALM Breathing Attendance
Acceptability Aim #2 CALM Breathing Satisfaction
Acceptability Aim #2 Drop-Out Rate
+1 more
Secondary outcome measures
6 mile Walking Distance Score (6MinWT)
COPD Assessment Test (CAT)
Chronic Respiratory Disease Questionnaire (CRQ) Score
+12 more

CALM Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CALM BreathingExperimental Treatment1 Intervention
Group II: Wait-List ControlActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CALM Breathing
2021
N/A
~50

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,719 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,431 Previous Clinical Trials
2,460,789 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
831 Previous Clinical Trials
668,891 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Capnography-Assisted Learned Monitored (CALM) Breathing Therapy for COPD
Annamaria R. Norweg 2021. "Capnography-Assisted Learned Monitored (CALM) Breathing Therapy for COPD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04786184.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top